Carmelo Pozzo

Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients

Carmelo Pozzo, Michele A. Basso, Alessandra Cassano et al. · Annals of Oncology · 2004 · 315 citations · Full text

Oncology, Hepatology, Gastrointestinal Oncology +10

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study

Carmelo Pozzo, C. Barone, J. Szántó et al. · Annals of Oncology · 2004 · 157 citations · Full text

Oncology, Esophageal Cancer, Esophageal-gastric Junction Adenocarcinoma +8

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases

Carlo Barone, Alessandra Cassano, Michele Basso et al. · British Journal of Cancer · 2007 · 125 citations · Full text

Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer

Ina Valeria Zurlo, Mattia Schino, Antonia Strippoli et al. · Cancer Immunology Immunotherapy · 2021 · 75 citations · Full text

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO

Daniele Rossini, Carlotta Antoniotti, Sara Lonardi et al. · Journal of Clinical Oncology · 2022 · 71 citations · Full text